The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma

被引：14

作者：

Colice, Gene L.

机构：

[1] Washington Hosp Ctr, Pulm Serv, Washington, DC 20010 USA

[2] Washington Hosp Ctr, Crit Care Serv, Washington, DC 20010 USA

[3] Washington Hosp Ctr, Resp Serv, Washington, DC 20010 USA

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2006年 / 7卷 / 15期

关键词：

asthma; ciclesonide; inhaled corticosteroid;

D O I：

10.1517/14656566.7.15.2107

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Ciclesonide is the most recently developed inhaled corticosteroid for the treatment of asthma to enter global markets. It has been formulated as an aerosol solution in a metered dose inhaler with hydrofluoralkane. The mass median aerodynamic diameter of aerosolised ciclesonide is 1 - 2 mu m, providing excellent lung deposition characteristics. Ciclesonide can undergo reversible esterification in the lungs, possibly allowing once-daily dosing, and is highly protein bound, possibly leading to reduced systemic side effects. Clinical trials suggest that ciclesonide effectively controls asthma and has a favourable safety profile.

引用

收藏

页码：2107 / 2117

页数：11

相关论文

共 54 条

[1] Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: A dose response study [J].

Agertoft, L ;

Pedersen, S .

EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (07) :1507-1512

[2] Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide [J].

Agertoft, L ;

Pedersen, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) :940-945

[3] Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].

Bateman, ED ;

Boushey, HA ;

Bousquet, J ;

Busse, WW ;

Clark, TJH ;

Pauwels, RA ;

Pedersen, SE .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844

[4] Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma [J].

Bateman, Eric ;

Karpel, Jill ;

Casale, Thomas ;

Wenzel, Sally ;

Banerji, Donald .

CHEST, 2006, 129 (05) :1176-1187

[5] Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma [J].

Belvisi, MG ;

Bundschuh, DS ;

Stoeck, M ;

Wicks, S ;

Underwood, S ;

Battram, CH ;

Haddad, EB ;

Webber, SE ;

Foster, ML .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (02) :568-574

[6]

Berger WE, 2005, THERAPY, V2, P167

[7] Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma [J].

Boulet, LP ;

Drollmann, A ;

Magyar, P ;

Timar, M ;

Knight, A ;

Engelstaetter, R ;

Fabbri, L .

RESPIRATORY MEDICINE, 2006, 100 (05) :785-794

[8]

Boulet LP, 1999, CAN MED ASSOC J, V161, pS1

[9] Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma [J].

Buhl, Roland ;

Vinkler, Ilona ;

Magyar, Pal ;

Gyori, Zsuzsa ;

Rybacki, Cezary ;

Middle, Michelle Vivienne ;

Escher, Armella ;

Engelstaetter, Renate .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (06) :404-412

[10] Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant [J].

Busse, WW ;

Brazinsky, S ;

Jacobson, K ;

Stricker, W ;

Schmitt, K ;

Vanden Burgt, J ;

Donnell, D ;

Hannon, S ;

Colice, GL .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) :1215-1222

← 1 2 3 4 5 6 →